Question

A government drug regulator believes that the toxicity level in a new drug is above the...

A government drug regulator believes that the toxicity level in a new drug is above the industry standard and is therefore unsafe for consumers. As the final arbitrator you are the person who has reviewed both the manufacture’s information and the government’s claim. You have the final authority to approve or deny this consumer drug …. Explain what would be a Type I and Type II error in this case. Which error would be more serious? Explain how both of these errors could be minimized simultaneously.

Homework Answers

Answer #1

H0 : toxicity level in a new drug is above the industry standard

H1 : toxicity level in a new drug is appropriate as per the industry standard

type I error : Rejecting H0 when it is true : If I pass the drug saying that the  toxicity level in a new drug is appropriate as per the industry standard but actually it is above the industry standard

type II error : Accepting H0 when it is false : If I do not pass the drug saying toxicity level in a new drug is above the industry standard but actually it is appropriate as per the industry standard

type I error is more serious. since, an inappropriate drug with higher  toxicity level as per the industry standard will be used

To reduce both the error simultaneously, the sample size of population being tested with drug should be increased

Know the answer?
Your Answer:

Post as a guest

Your Name:

What's your source?

Earn Coins

Coins can be redeemed for fabulous gifts.

Not the answer you're looking for?
Ask your own homework help question
Similar Questions
A government drug regulator believes that the toxicity level in a new drug is above the...
A government drug regulator believes that the toxicity level in a new drug is above the industry standard and is therefore unsafe for consumers. As the final arbitrator you are the person who has reviewed both the manufacture’s information and the government’s claim. You have the final authority to approve or deny this consumer drug …. Explain what would be a Type I and Type II error in this case. Which error would be more serious? Explain how both of...
Can you please thoroughly answer these questions: 1.   Explain the incentives faced by a Federal Drug...
Can you please thoroughly answer these questions: 1.   Explain the incentives faced by a Federal Drug Administration drug inspector whose actions and deliberations will determine whether a drug is allowed to be produced or sold to Americans. How is it possible for them to ignore those who die from the delayed introduction of a drug? Make sure to distinguish between Type I and Type II errors. 2.       What is the difference between an invention and an innovation? Explain why inventions may...
Pfizer was established in 1849 in Brooklyn, New York by cousins Charles Pfizer and Charles Erhart...
Pfizer was established in 1849 in Brooklyn, New York by cousins Charles Pfizer and Charles Erhart with a loan of $2,500 from Pfizer’s father.2 Today, 167 years later, Pfizer Inc. has international revenues of $49 billion, which makes it the second-largest pharmaceutical manufacturer in the world.3 Despite Pfizer’s success, the company has faced many challenges over the last few decades. The pharmaceutical industry is heavily influenced by legal, political, and technological forces, and all indications are that the industry will...
In February 2012, the Pepsi Next product was launched into the US market. This case study...
In February 2012, the Pepsi Next product was launched into the US market. This case study provides students with an interesting insight into PepsiCo’s new product process and some of the challenging decisions that they faced along the way. Pepsi Next Case Study Introduction Pepsi Next was launched by PepsiCo into the US market in February 2012, and has since been rolled out to various international markets (for instance, it was launched in Australia in September 2012). The new product...
Please answer the following Case analysis questions 1-How is New Balance performing compared to its primary...
Please answer the following Case analysis questions 1-How is New Balance performing compared to its primary rivals? How will the acquisition of Reebok by Adidas impact the structure of the athletic shoe industry? Is this likely to be favorable or unfavorable for New Balance? 2- What issues does New Balance management need to address? 3-What recommendations would you make to New Balance Management? What does New Balance need to do to continue to be successful? Should management continue to invest...
Mattel Responds to Ethical Challenges Business Ethics This case was written by Debbie Thorne, John Fraedrich,...
Mattel Responds to Ethical Challenges Business Ethics This case was written by Debbie Thorne, John Fraedrich, O. C. Ferrell, and Jennifer Jackson, with the editorial assistance of Jennifer Sawayda. This case was developed for classroom discussion rather than to illustrate either effective or ineffective handling of an administrative, ethical, or legal discussion by management. All sources used for this case were obtained through publicly available material. Mattel, Inc. is a world leader in the design, manufacture, and marketing of family...
ADVERTISEMENT
Need Online Homework Help?

Get Answers For Free
Most questions answered within 1 hours.

Ask a Question
ADVERTISEMENT